Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTT3P91)

DTT Name	Synaptic vesicle glycoprotein 2A (SV2A) DTT Info
Gene Name	SV2A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Discontinued Drug(s)

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

2 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Brivaracetam	DMSEPK8	Complex partial seizure	8A68.0	Approved	[1]
Levetiracetam	DMTGDN8	Epilepsy	8A60-8A68	Approved	[2]
------------------------------------------------------------------------------------

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Padsevonil	DMRZ1F2	Epilepsy	8A60-8A68	Phase 2/3	[3]
------------------------------------------------------------------------------------

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Seletracetam	DM3IJMN	Epilepsy	8A60-8A68	Discontinued in Phase 3	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Pharmacological management of epilepsy: recent advances and future prospects. Drugs. 2008;68(14):1925-39.
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3	Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models. J Pharmacol Exp Ther. 2020 Jan;372(1):11-20.
4	Emerging drugs for epilepsy. Expert Opin Emerg Drugs. 2007 Sep;12(3):407-22.